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A B S T R A C T
This study was undertaken to examine the alteration of masseter and plasma interleukin-6 after inducing occlusal
interference and chronic stress. Male Wistar rats were submitted to chronic stress procedure, exposed to occlusal interfer-
ence, or exposed to both mentioned procedures. Whole blood and masseter tissue were collected to determine interleukin-6
level, measured by means of ELISA. Masseter pain was evaluated using the orofacial formalin test. Masseter inter-
leukin-6 level was significantly higher in animals submitted to combination of occlusal interference and chronic stress
than in the control group (p<0.05). There was positive and significant correlation between pain response and masseter
interleukin-6 level (r=0.5741; p<0.0003). No significant differences in plasma interleukin-6 level were found between
groups (p>0.05), as well as no correlation with pain (p>0.05). Combination of occlusal interference and chronic stress
leads to strong local reaction characterized by high levels of masseter interleukine-6. High concentrations of muscle
interleukin-6 and its correlation with pain point to inflammatory background of masticatory muscle pain.
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Introduction
Pain in the masticatory muscles has long been recog-
nized as a prominent symptom of temporomandibular
disorder (TMD)1, but still the etiopathogenesis of this
disorder is not well understood. There is no consensus
about the involvement of occlusal alteration and psycho-
logical stressors in development of masticatory muscle
pain, although many studies point to their contributing
role2–5. Our previous study on experimental animals shows
that conditions where occlusal interference and chronic
stress act together are capable to induce masseter muscle
pain6. Occlusal interference is considered to be a factor
that contributes to the masticatory muscle hyperactivity
causing muscle spasm and microtraumatic changes in
temporomandibular joints (TMJ) characterized by high
levels of proinflammatory cytokines, which implicates
that muscle pain has its origin in tissue inflammation7–10.
Interleukin-6 (IL-6) is a pleiotropic cytokine that influen-
ces immune responses and inflammatory reactions. To-
gether with IL-1 and TNF-a, it belongs to the group of
main proinflammatory cytokines11. IL-6 plays a relevant
role in the development and maintenance of muscular
hyperalgesia12. Patients with TMD express higher levels
of chronic daily stressors, depression and other psycho-
logical disturbances which are associated with high lev-
els of proinflammatory cytokines13–15. Some studies have
found an association between the symptoms of TMD and
the increased levels of proinflammatory cytokines in
synovial fluid of temporomandibular joints suggesting
their role in the development of the disorder16,17. While
the change of cytokine level in the synovial fluid of TMJ
has been described within the response to TMD, there is
a lack of studies dealing with changes in the masticatory
muscles despite the fact that 10 % of TMD patients have
masticatory muscle symptoms1. The objective of this
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study was to investigate whether proposed conditions,
occlusal interference and chronic stress, cause alteration
in the masseter muscle and plasma IL-6 level and if there
is correlation between IL-6 and pain response.
Materials and Methods
Animals. Adult male Wistar rats (weight 250–300 g)
were used in this study. Animals were maintained on a 12
h light–dark cycle and allowed free access to food and wa-
ter. All experiments were performed between 10 a.m. and
2 p.m. in a silent room, at a temperature of 22°C–24°C.
All experimental procedures involving animals were per-
formed in accordance with the regulations set by the Cro-
atian related laws and rules (NN 19/99; NN 176/04) and
with the guidelines set by the European Community
Council Directive of 24 November 1986 (86/609/EEC).
All experimental procedures were also approved by the
Faculty ethical committee. The rats were randomly di-
vided in chronic stress group (n=10), occlusal interfer-
ence group (n=10), group with both occlusal interference
and chronic stress (n=10) and control group (n=10) free
of experimental procedures. Animals participated in the
experiment for 56 days. Pain response was tested using
the formalin test, and plasma and masseter muscle sam-
ples collected for further analysis. In order to exclude the
possibility that changes in the IL-6 level are a conse-
quence of formalin injection in the masseter muscle
(used for pain valorization) we introduced another, abso-
lute control group of rats (n=10), free of any experimen-
tal procedure and not subject to the formalin test.
Chronic Stress procedure
The rats were stressed by restrain 1 h/day, 5 days/
week for 8 weeks as previously reported18. Briefly, res-
traint was carried out by placing the animal in a 7x30 cm
plastic tube. Tube was designed with inner mobile wall,
so it could be adjustable in size, depending on each ani-
mal, and could disable them to move. At the far end of
the tube there was a 1 cm hole for breathing.
Occlusal interference procedure
Rats remained unstressed in their cages until the 48th
day, when occlusal splint was fitted. They were sedated
with chloral hydrate (300 mg/kg) and occlusal splint was
built-up on the maxillary molar teeth6,19,20. Briefly, before
placing the splint, the teeth were etched with 37% phos-
phoric acid, washed with water and air-dried. Composite
resin (Gradia direct, GC Dental products corp., Aichi, Ja-
pan) was built-up (height of 1.0 mm) unilaterary on up-
per right molar teeth. To prevent the reduction of mate-
rial during function, antagonist right lower molar teeth
were coated with fluid resin. Occlusal interference was
left in place for 8 days.
Combination of occlusal interference and chronic
stress procedure
To evaluate the mutual effect of occlusal interference
and chronic stress on IL-6 levels, animals were exposed
to both experimental procedures. First the animals were
exposed to the chronic stress procedure, the same way as
described above, and than, on the 48th day, occlusal inter-
ference on the right upper molar teeth was fitted. Throu-
ghout the next eight days, until the completion of the ex-
periment, animals were exposed to both stress procedure
and occlusal interference6.
Testing procedure for the masseter muscle pain
On the 56th experimental day pain response was eva-
luted using the orofacial formalin test as previously re-
ported 6,21,22. Briefly, a volume of 0.05 ml, 5% formalin in
saline was injected into the mid-region of the right mas-
seter muscle via 27 gauge needle. The behavioral re-
sponses, characterized by rubbing orofacial region (amo-
unt of time) and flinching the head (number of head
flinches), were quantified within a 45 min period. Pain
response was evaluated as the sum of time spent on rub-
bing and flinching, expressed in seconds.
IL-6 determination
Immediately after the behavioral response was ana-
lyzed, all animals were decapitated and the masseter tis-
sues from occlusal interference side as well as blood sam-
ples were taken. Right masseter muscle was removed,
frozen in liquid nitrogen, and stored at –80°C. For cyto-
kine assay, masseter samples were weighed and homoge-
nized in phosphate-buffer saline (PBS, pH 7.4) contain-
ing 0.4 mol/L NaCl, 0.05% Tween-20, 0.5 bovine serum
albumin, 0.1 mmol/L benzethonium chloride, 10 mmol/L
EDTA, and 20 KI/L aprotinin. The homogenates were
centrifuged at 2 000xg for 60 min at 4°C. The super-
natant was removed and analyzed as was the plasma.
Blood samples were directly centrifuged at 20.200 ´ g for
10 min, and the supernatant was isolated. IL-6 levels
were determined using an enzyme-linked immunosor-
bent assay (Interleukin-6 (rat) ELISA, IBL-Hamburg,
GmbH, Germany) for the quantitative detection of rat
IL-6 according to manufacturer’s instructions. The re-
producibility of this examination was confirmed by pro-
cessing all the samples twice.
Statistical analysis
GraphPad Prism 4.0 software (Graph-Pad Software,
San Diego, CA) was used for the statistical analysis.
Since the data were not normally distributed (Kolmogo-
rov-Smirnov test), the differences in plasma and tissue
IL-6 levels among all groups were tested using Kru-
skal-Wallis test followed by Dunn’s method for post-hoc
comparisons. Spearman’s rank correlation coefficients
were calculated when investigating the relationship be-
tween IL-6 level and nociceptive response. A probability
level of less then 0.05 was considered to indicate statisti-
cal significance.
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Results
The results of pain response have been published in
the first report from our experiment6. In brief, signifi-
cant alteration in pain threshold was found only in ani-
mals exposed to both occlusal interference and chronic
stress, when compared to the control group.
Kruskal-Wallis test revealed significant differences in
the masseter IL-6 level between the groups (p=0.0047)
(Figure 1). There were no differences in the muscle IL-6
levels after exposure to occlusal interference (p>0.05).
Chronic stress also had no effect on IL-6 level (p>0.05) in
comparison with the control group. The increase of mas-
seter IL-6 was statistically significant (p<0.01) between
the control group and the group with combination of
both occlusal interference and chronic stress. There were
no differences in masseter IL-6 between the control
group and the absolute control group (p>0.05). Kru-
skal-Wallis test showed no significant difference in plas-
ma IL-6 levels between groups (p=0.1115, Figure 2). Ex-
perimentally induced occlusal interference, chronic stress
or their combination did not affect plasma IL-6 levels.
Correlation analysis demonstrated that masseter IL-6
level was significantly and positively correlated to the no-
ciceptive behavioral response (r=0.5741; p<0.0003, Fig-
ure 3). There was negative, but not significant, correla-
tion between plasma IL-6 level and the pain response
(r=–0.2780; p=0.0996, Figure 4).
Discussion and Conclusion
In this study, by inducing occlusal changes and a
chronic daily stressor, local and systemic changes in IL-6
under conditions which are common in patients with
masticatory muscle pain were investigated23,24. In order
to exclude the possibility that changes in IL-6 levels are
consequence of formalin injection used for valorization of
pain response, another group of rats was introduced.
This absolute control group of animals was free of any
experimental procedure and not subject to the formalin
test. Since formalin solution injected into masseter mus-
cle did not induce changes in the tissue IL-6 level, differ-
ences have to be a consequence of experimentally indu-














































Fig. 1. Changes in masseter muscle IL-6 level after inducing oc-
clusal interference, chronic stress and combination of occlusal
interference and chronic stress. The level of IL-6 increased signi-
ficantly following combination of occlusal interference and chro-
nic stress compared with the control group, while there were no
differences between occlusal interference or chronic stress group
compared with the control group. Note that there was no signifi-
cant change between absolute control and control group. Data are
presented as mean ±S.E.M. Asterisk shows a significant differen-















































Fig. 2. Plasma IL-6 levels after inducing occlusal interference,
chronic stress and combination of occlusal interference and chro-
nic stress. There were no statistically significant differences in
plasma IL-6 levels between groups. Experimental procedures do
not influence plasma IL-6 level. Data are presented as mean±
S.E.M. (p>0.05, Kruskal-Wallis).

















Fig. 3. Correlation between masseter IL-6 and nociceptive behavi-
oral response. There is significant and positive association (r=
0.5741; p<0.0003) between the masseter muscle IL-6 level and
nociceptive behavioral response examined by Spearman’s rank cor-
relation.















Fig. 4. Correlation between plasma IL-6 and nociceptive
behavioral response. There is negative, but not significant
association (r=–0.2780; p=0.0996) between the plasma IL-6
level and nociceptive behavioral response examined by Spe-
arman’s rank correlation.
ced chronic stress and occlusal interference. This result
is in agreement with previous reports indicating that lo-
cal injection of inflammatory substances does not induce
cytokine alterations in a period shorter than one hour,
with a peak at 6 hours after injection10.
Pain is one of the common sensations which usually
indicates tissue damage as a consequence of various ex-
ternal or internal factors25. From the results of our previ-
ous report it seems that masticatory muscles are capable
to adapt to minor occlusal changes and chronic stress
without developing the changes in pain response, but
when this two proposed etiological factors work together
they cause a higher pain response6. In the present study,
similarly to pain response results, there was a lack of sig-
nificant changes in both tissue and plasma IL-6 levels be-
tween the chronically stressed animals and rats with
occlusal interference in comparison to the control group,
while masseter IL-6 significantly increased in animals
submitted to combination of experimental procedures.
These results suggest that only the combination of oc-
clusal interference and chronic stress leads to a strong lo-
cal inflammatory reaction characterized by the alter-
ation in masseter IL-6 level. Results of other studies
showed increased levels of IL-6, prostaglandins, seroto-
nin, and growth factors in muscle tissue after the con-
traction and muscle damage26,27. Also, cytokines (IL-6,
IL-1, IL-8, TNF-a) and prostaglandins, when locally in-
jected, influence nociception causing hyperalgesia28,29.
Contrary to positive association between pain response
and masseter muscle IL-6 level found in this study, in
most plasma samples the IL-6 level was below the detect-
able limit of the assay and there were no differences in
plasma IL-6 levels between groups as well as no correla-
tion with pain. Although not significant, there was a neg-
ative correlation coefficient between the pain and blood
IL-6 level. Low level of blood IL-6 found in this study, es-
pecially in the group with combination of occlusal inter-
ference and chronic stress and negative correlation coef-
ficient regarding to pain response point to the difference
between local and systemic cytokine response. It has
been sugested that blood IL-6 level does not depend on
its local level and in contrarary to local proinflammatory
reaction, the sistemic cytokine response might be di-
rected towards suppression of inflammatory reaction10,30.
The differences between the local and circulating IL-6 re-
sponse may be partly due to the fact that circulating
cytokines have a relatively short half-life in the plasma30.
Although cytokines can affect pain response through
changes in the central nervous system31–33, elevated lev-
els of IL-6 in the masseter muscle and its positive associ-
ation with pain as well as no changes in plasma IL-6
found in this study lead to conclusion that combination
of proposed etiological factors, chronic stress and oc-
clusal interference, influence pain response trough local-
ized mechanisms and that IL-6 is one of the cytokines re-
sponsible for developing masticatory muscle pain. This is
in agreement with previous studies which suggest that
pain is mainly caused by prolonged excitation of periph-
eral nociceptors by IL-634,35.
In conclusion, this study strengthens the knowledge
on inflammatory background of disorder and highlights
the role of local IL-6 in masticatory muscle pain. Oro-
facial pain is extremely complex and further studies are
needed to examine the role of local and circulating levels
of other potential mediators of muscle pain and/or in-
flammation, as they are beyond the scope of this study.
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PROMJENE RAZINE IL-6 U MASETERI^NOM MI[I]U I PLAZMI NAKON EKSPERIMENTALNO
IZAZVANE OKLUZIJSKE INTERFERENCIJE I KRONI^NOG STRESA
S A @ E T A K
Cilj istra`ivanja bio je ispitati promjene u razini interleukina-6 u maseteri~nom mi{i}u i plazmi nakon izazivanja
okluzijske interferencije i kroni~nog stresa. Mu{ki Wistar {takori izlo`eni su kroni~nom stresu, okluzijskoj interferen-
ciji, ili objema spomenutim procedurama. Skupljeni su uzorci krvi i tkiva maseteri~nog mi{i}a te su iz njih utvr|ene
vrijednost interleukina-6, ELISA metodom. Bol maseteri~nog mi{i}a vrednovana je orofacijalnim formalinskim testom.
Razina interleukina-6 maseteri~nog mi{i}a bila je statisti~ki zna~ajno povi{ena u `ivotinja podvrgnutih zajedni~kom
djelovanju okluzijske interferencije i kroni~nog stresa, u usporedbi s kontrolnom skupinom (p<0,05). Utvr|ena je pozi-
tivna i zna~ajna korelacija izme|u boli i razine interleukina-6 maseteri~nog mi{i}a (r=0,5741; p<0,0003). Razlika razi-
ne interleukina-6 u plazmi nije pokazala statisti~ku zna~ajnost izme|u skupina (p>0,05), niti je utvr|ena zna~ajna
korelacija s boli (p>0,05). Zajedni~ko djelovanje okluzijske interferencije i kroni~nog stresa vodi sna`noj lokalnoj re-
akciji okarakteriziranoj visokom razinom interleukina-6 u maseteri~nom mi{i}u. Visoka razina mi{i}nog interleukina-6
i korelacija s boli ukazuju da bol `va~ne muskulature ima podlogu u upali.
